Insider purchase details
According to a Form 4 filing with the Securities and Exchange Commission, Director Alexander Duka of BCP Investment Corp (NASDAQ: BCIC) purchased 2,000 shares of the company’s common stock on March 20, 2026. The shares were acquired at $7.335 each, for a total transaction value of $14,670. After the trade, Duka is recorded as directly owning 3,000 shares, held jointly with a spouse.
Market context and valuation snapshot
The insider purchase occurred while BCIC was trading close to its 52-week low of $7.15. The stock has fallen roughly 10% over the past week. At present, BCIC is trading at a price-to-earnings ratio of 7.05 and a dividend yield of 21.75%, data points that accompany the recent insider filing.
Recent financial results
BCP Investment reported quarterly results for the fourth quarter of 2025 that outpaced analyst expectations on both earnings and revenue. The company posted earnings per share of $0.57, beating the consensus estimate of $0.5325 by 7.04%. Reported revenue for the period was $17.5 million, compared with an anticipated $16.98 million.
Analyst action and company performance details
Despite the reported EPS and revenue beats, Keefe, Bruyette & Woods reduced its price target on BCP Investment shares from $14.00 to $9.00 while retaining a Market Perform rating. The firm cited a difficult quarter in which net investment income fell short of expectations. The company also reported a 7% operating return on equity for the quarter and experienced a 5% decrease in net asset value during the period.
Additional subscriber resources
Subscribers to InvestingPro have access to further analysis and 12 additional ProTips for BCIC, which include additional detail on the company’s financial health and valuation metrics.
Summary perspective
The insider acquisition by Director Alexander Duka adds a layer of detail to BCIC’s current profile — a modest purchase executed while the stock trades near its 52-week low and following a quarter that produced mixed signals: an EPS and revenue outperformance alongside weaker net investment income, a lowered analyst price target, and a decline in net asset value.